Influence of hepcidin on iron metabolism

• Autorzy: Kosla T , Skibniewska E.M.
• Języki publikacji: EN

Abstrakty

EN

The main role of iron is being part of haemoglobin, whose level it stabilizes; however, iron also plays a very important role in immunological processes and the metabolism of the organism. Hepcidin is a peptide hormone. It was first isolated from human blood and urine, and its release was attributed to the liver. A failure to produce hepcidin is related to iron overload, while its excessive production to anaemia caused by iron deficit. The releasing of hepcidin also affects hypoxia and inflammation through inhibiting these processes in patients with haemochromatosis. There are three forms of the regulation of the iron level: the first is a regulation in cellular storages, the second is erythropoiesis and the third is a dietary regulator. Hepcidin was identified as a regulator which communicates the level of iron reserves in the organism to intestine cells responsible for the absorption of iron. In inflammatory conditions, when the organism wishes to cause alimentary iron deficit, hepcidin production increases even a hundred fold, thus leading to anaemia. Hepcidin is also a stimulator of inflammation as an antibacterial factor produced in the liver parenchyma. It decreases the absorption of iron in the intestines and increases the secretion of iron to the reticuloendothelial system. Experiments on animals deprived of hepcidin and animals with its excess make it possible to understand iron homeostasis and confirm the role of hepcidin as a hormone regulating iron metabolism.

Słowa kluczowe

EN

peptide hormone; hepcidin; metabolism; iron metabolism; absorption; anaemia; human organism; animal organism

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2010
• Tom: 66
• Numer: 05
• Opis fizyczny: p.291-293,ref.

Twórcy

autor

Kosla T

• Warsaw University of Life Sciences - SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland

autor

Skibniewska E.M.

Bibliografia

• 1. Alsen P., Enns C., Wessling-Resnick M.: Chemistry and biology of eucaryotic iron metabolism. Internat. J. Biochem. Cell Biol. 2001, 33, 940-959.
• 2. Andrews N. C.: Metal transporters and disease. Curr. Opin. Chem. Biol. 2002, 6,181-186.
• 3. Andrews N. C., Roy C. N.: Forging iron links. Blood 2003, 101, 2450.
• 4. Arnold J., Sangwaiya A., Bhatkal B., Arnold A.: Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis. Med. Hypoth. 2008, 70, 1197-1200.
• 5. Bednarek D., Kondracki M.: Bioelements and an animal immunity, [in:] Siwicki A. K. (ed): The effect of xenobiotics on immunity system. Inland Fisheries Institute, Olsztyn 1997, 85-94.
• 6. Ben-Assa E., Youngster I., Kozer E., Abu-Kishk I., Bar-Haim A., Bar-Oz B., Berkovitch M.: Changes in serum hepcidin levels in acute iron intoxication in a rat model. Toxicol. Lett. 2009, 189, 242-247.
• 7. Bridle K. R., Frazer D. M., Wilkins S. J., Dixon J. L., Purdie D. M., Crawford D. H., Subramanian V. N., Powell L. W., Anderson G. J., Ramm G. A.: Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homeostasis. Lancet 2003, 361, 669-673.
• 8. Chung J., Wessling-Resnick M.: Molecular mechanisms and regulation of iron transport. Crit. Rev. Clin. Lab. Sci. 2003, 40, 151-182.
• 9. Collins H. L.: The role of iron in infections with intracellural bacteria. Immunol. Lett. 2003, 85, 193-195.
• 10. Ganz T.: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102, 783-788.
• 11. Ganz T.: Molecular control of iron transport. J. Am. Soc. Nephrol. 2007, 18, 394-400.
• 12. Guo P., Cui R., Chang Y. Z., Wu W. S., Qian Z. M., Yoshida K., Qiao Y. T., Takeda S., Duan X. L.: Hepcidin, an antimicrobial peptide is downregulated in ceruloplasmin-deficient mice. Peptides 2009, 30, 262-266.
• 13. Hunter H. N., Fulton D. B., Ganz T., Vogel H. J.: The solution structure of human hepcidin a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. 2002, 277, 37597-37603.
• 14. Jurczyk K.: The role of iron in liver diseases. Med. Sci. Progress 2000, 1, 1-5.
• 15. Kleczkowski M., Kluciński W., Sikora J., Kasztelan R.: Rola wybranych składników mineralnych w procesach oksydacyjnych organizmu. Medycyna Wet. 2004, 60, 242-245.
• 16. Krause A., Neitz S., Mägert H. J., Schultz A., Forssmann W. G., Schultz-Knappe P., Andermann K.: LEAP-1, a novel highly disulfite-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000, 480, 147-150.
• 17. Kushner J. P., Porter J. P., Olivieri N. F.: Secondary iron overload. Hematology 2001, 1, 47-61.
• 18. Leong W. I., Lönnerdal B.: Hepcidin, the recently identified peptide that appears to regulate iron absorption. J. Nutrition 2004, 134, 1-4.
• 19. Mazur A., Feillet-Coudray Ch., Romier B., Bayle D., Gueux E., Ruivard M., Coudray Ch., Rayssiguier Y. Z.: Dietary iron regulates hepcidin 1 and 2 mRNA in mice. Metabolism Clin. Exp. 2003, 52, 1229-1231.
• 20. Muckenthaler M., Roy C. N., Custodio A. O., Minana B., Degraaf J., Montross L. K., Andrews N. C., Hentze M. W.: Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd l expression in mouse hemochromatosis. Nat. Genet. 2003, 34, 102-107.
• 21. Nemeth E., Valore E. V., Territo M., Schiller G., Lichtenstein A., Ganz T.: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101, 2461-2463.
• 22. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., Vaulont S.: Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Nat. Acad. Sciences USA 2001, 98, 8780-8785.
• 23. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., Sirito M., Sawadogo M., Kahn A., Vaulont S.: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Nat. Acad. Sciences USA 2002a, 99, 4596-4601.
• 24. Nicolas G., Chauvet C., Viatte L., Danan J. L., Bigard X., Devaux I., Beaumont C., Kahn A.: Vaulont SThe gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 2002b, 110, 1037-1044.
• 25. Nicolas G., Viatte L., Lou D.-Q., Bennoun M., Beaumont C., Kahn A., Andrews C., Vaulont S.: Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nature Genetics 2003, 34, 97-101.
• 26. Park C. H., Valore E. V., Waring A. J., Ganz T.: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001, 276, 7806-7810.
• 27. Pigeon C., Ilyin G., Courseland B., Leroyer P., Turlin B., Brissot P., Loreal O.: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 2001, 276, 7811-7819.
• 28. Roy C. N., Weinstein D. A., Andrews N. C.: Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr. Res. 2003, 53, 507-512.
• 29. Sokołowska E., Klimek J.: Hepcydyna - hormon uczestniczący w regulacji metabolizmu żelaza w organizmie. Post. Biol. Kom. 2007, 34, 15-30.
• 30. Toledano M., Kozer E., Goldstein L. H., Abu-Kishk I., Bar-Haim A., Siman-Tov Y., Rechavi M., Rechavi G., Weizer-Stern O., Berkovitch M.: Hepcidin in acute iron toxicity. Am. J. Emergency Med. 2009, 27, 761-764.
• 31. Wang K. J., Cai J. J., Cai L., Qu H. D., Yang M., Zhang M.: Cloning and expression of a hepcidin gene from a marine fish (Pseudosciaena crocea) and the antimicrobial activity of its synthetic peptide. Peptides 2009, 30, 638-646.
• 32. Weinstein D. A., Roy C. N., Fleming M. D., Loda M. F., Wolfsdorf J. I., Andrews N. C.: Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002, 100, 3776-3781.
• 33. Weiss G.: Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 2002, 16, 87-96.
• 34. Zhang A.-S., Xiong S., Tsukamoto H., Enns C. A.: Localization of iron metabolism related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 2004, 103, 1509-1514.